Moreover, it is evident that the identification of a specific receptor mediating the influence of WNT1 on bone formation and matrix integrity might pave the way to develop additional osteoanabolic treatment options for various bone loss disorders, including osteoporosis. Here, WNT1 is linked to osteoporosis.